- $69.11m
- $597.42m
- $144.58m
Annual cashflow statement for Stem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -156 | -101 | -124 | -140 | -854 |
| Depreciation | |||||
| Non-Cash Items | 101 | 35 | 40 | 4.65 | 713 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.6 | -59.5 | -67.4 | -118 | 59.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -33.7 | -101 | -106 | -207 | -36.6 |
| Capital Expenditures | -12 | -10.2 | -20.9 | -18.2 | -11.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -175 | -524 | 154 | 8.25 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -12 | -185 | -544 | 136 | -3.52 |
| Financing Cash Flow Items | 0 | 538 | -1.76 | -0.056 | 0.056 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 40.3 | 1,027 | -9.27 | 90.2 | -8.44 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.95 | 741 | -660 | 18.6 | -48.4 |